Alabama recalls

Fresenius Kabi Compounding has recalled vancomycin HCl 2-gram doses mixed in sodium chloride solution due to concerns that sterility cannot be assured. The affected lots were distributed nationwide. This is a serious issue because non-sterile injectables can cause life-threatening infections.

Fresenius Kabi Compounding issued a recall of vancomycin HCl 1.5 grams in 500 mL sodium chloride solution due to lack of assured sterility. The affected lot (C274-000049628, expiring May 3, 2026) was distributed nationwide to healthcare facilities. No injuries have been reported.

Fresenius Kabi Compounding has recalled multiple lots of thiamine HCl 500 mg injection because the manufacturer cannot confirm the product is sterile. This injectable medication was distributed nationwide. The recall affects 10,548 bags with expiration dates between February and May 2026.

Fresenius Kabi Compounding has recalled five specific lots of ketamine HCl injection (10 mg per mL) distributed nationwide because the manufacturer cannot confirm the product remains sterile. The affected lots were produced between February and April 2026.

Fresenius Kabi Compounding has recalled acyclovir sodium 200 mg IV injection bags because the manufacturer cannot guarantee the product is sterile. The affected bags were produced by Fagron Sterile Services and have lot number C274-000049124 with an expiration date of February 28, 2026. No infections or injuries have been reported so far.

Asteria Health is recalling specific lots of testosterone 100mg/anastrozole 4mg sterile pellets due to potential metal particulate matter in the product. The contamination was discovered during quality testing. No injuries have been reported.

Asteria Health has recalled a specific lot of testosterone and triamcinolone acetonide pellets because they may contain metal particulate matter. This contamination was discovered during manufacturing. The affected lot is 256000103, which expires July 28, 2026.

Asteria Health is recalling a hormone medication pellet containing testosterone and triamcinolone due to the potential presence of metal particulate matter in the product. The recall affects lot 256000105 with an expiration date of September 19, 2026, distributed nationwide. No injuries have been reported.

Asteria Health is recalling a testosterone and triamcinolone acetonide combination pellet due to the potential presence of metal particulate matter in the product. The recall affects lot #256000104 with an expiration date of 07/30/2026, distributed nationwide. No injuries have been reported.

Asteria Health is recalling specific lots of testosterone 75mg/anastrozole 4mg sterile pellets due to potential metal particulate matter found in the product. The affected lots were distributed nationwide. No injuries have been reported.

Asteria Health is recalling one lot of testosterone 100mg/anastrozole 4mg pellets because they may contain metal particles. The affected lot (254000104, expiring 05/27/2026) was distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (303 mg) may contain metal particulate matter that could contaminate the product. The recall affects 1,015 pellets from lot #251000124 with an expiration date of 06/02/2026 distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (200 mg) may contain metal particulate matter due to a manufacturing issue. The FDA has classified this as a Class II recall affecting multiple lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling certain testosterone pellet injections because they may contain metal particulate matter. The contamination was identified in seven specific manufacturing lots with expiration dates between June 2026 and September 2026. No injuries have been reported so far.

Asteria Health is recalling testosterone pellets (87.5 mg) because they may contain metal particles. The recall affects three specific lots distributed nationwide. No injuries have been reported so far.

Asteria Health testosterone pellets (62.5 mg) may contain metal particulate matter. The affected lot (251000125, expiring 06/02/2026) was distributed nationwide. About 1,758 pellets are involved in this recall.

Asteria Health testosterone pellets may contain metal particulate matter as a result of a manufacturing issue. The recall affects specific lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health's testosterone pellets may contain metal particulate matter due to a manufacturing issue. The FDA has identified five affected lot numbers distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (25 mg) may contain metal particulate matter due to a manufacturing issue. The FDA has classified this as a Class II recall affecting multiple lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling testosterone pellets (18.0 mg, lot #251000126, expiring 06/03/2026) because they may contain metal particulate matter. The recall affects 146 pellets distributed nationwide. No injuries have been reported.

Asteria Health testosterone pellets (12.5 mg) may contain metal particulate matter due to a manufacturing issue. The recall affects specific lots distributed nationwide. No injuries have been reported to date.

Asteria Health's estradiol 37.5 mg sterile pellets may contain metal particulate matter. This affects lot 253000125, expiring 06/09/2026. No injuries have been reported to date.

Asteria Health estradiol 25 mg pellets may contain metal particulate matter. The affected lot (253000136, expiring 07/01/2026) was distributed nationwide. No injuries have been reported.

Asteria Health is recalling estradiol 22 mg pellets (Lot# 253000126, expiring 06/09/2026) because they may contain metal particulate matter. The recall affects 133 pellets distributed nationwide. No injuries have been reported.

Asteria Health's estradiol 20 mg hormone pellets may contain metal particulate matter. This affects one specific lot (253000124) with an expiration date of June 2, 2026, distributed nationwide. No injuries have been reported.

Asteria Health is recalling estradiol pellets (18 mg) because some may contain metal particulate matter. The affected lot was distributed nationwide. No injuries have been reported.

Asteria Health estradiol 15 mg pellets may contain metal particulate matter, a foreign substance that could pose a health risk. The FDA has identified four affected lot numbers distributed nationwide. No injuries have been reported to date.

Asteria Health estradiol pellets (12.5 mg) may contain metal particulate matter. The affected lots were distributed nationwide. No injuries have been reported to date.

Asteria Health is recalling estradiol hormone pellets (10 mg) because they may contain metal particles. The affected pellets were distributed nationwide. No injuries have been reported so far.

Presence of Foreign substance - potential presence of metal particulate matter